• -
61 Results
Download CSV
Marijuana Law
Drug Policy | Commentary
Anderson vs. Ogg for D.A.: Both Have New Plans for Marijuana, but Which Is Better?
In the current campaign for Harris County district attorney, both incumbent D.A. Devon Anderson and challenger Kim Ogg have not only proposed to change the way marijuana use is handled by that office, but have also made the issue a centerpiece of their campaigns. Drug policy fellow Katharine Neill examines each candidate’s proposed changes in a new Baker Institute Blog.
Katharine Neill Harris October 30, 2014
Marijuana Law
Latin America Initiative | Commentary
Marijuana Decriminalization in the Caribbean
Governments of the Caribbean Community and Common Market (CARICOM) have called for a discussion on the decriminalization of marijuana after a pilot study found that legalized medical marijuana sales could boost the region’s ailing economies. As a result, the topic was an important agenda item at a CARICOM Inter-Sessional Heads of State Summit held in March 2014. Two aspects of decriminalization were discussed: decriminalization for medical use and decriminalization for recreational use.
August 15, 2014
Vaccine
U.S. Health System Transformation | Center for Health and Biosciences | Commentary
Chemotherapy Drug Shortages in the U.S. — The Recurring Nightmare
Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.
Hagop M. Kantarjian, Vivian Ho March 13, 2014